111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioconjugate chemistry

• Publication date

  2008-01-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/bc700317wPMID 18197608PMCID PMC3617549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2007

  2007cited by this paper
• (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.

  2007cited by this paper
• 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.

  2007cited by this paper
• Evaluation of a 99mTc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin αvβ3-Positive Breast Cancer

  2007cited by this paper
• Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides

  2007cited by this paper
• 64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor αvβ3 Integrin Expression

  2007cited by this paper
• Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.

  2007cited by this paper
• Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.

  2007cited by this paper
• Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.

  2007cited by this paper
• Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues.

  2006cited by this paper
• Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer.

  2006cited by this paper
• Design of cyclic and other templates for potent and selective peptide alpha-MSH analogues.

  2005cited by this paper
• Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

  2005cited by this paper
• Melanoma therapy via peptide-targeted {alpha}-radiation.

  2005cited by this paper
• Design of cyclic and other templates for potent and selective peptide α-MSH analogues

  2005cited by this paper
• Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.

  2005cited by this paper
• microPET Imaging of Glioma Integrin αvβ3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide

  2005cited by this paper
• Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.

  2005cited by this paper
• Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.

  2005cited by this paper
• Melanoma Therapy via Peptide-Targeted α-Radiation

  2005cited by this paper
• microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

  2005cited by this paper
• A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.

  2004cited by this paper
• Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose.

  2004cited by this paper
• -Melanocyte–Stimulating Hormone Peptide Analog in Murine and Human Melanoma-Bearing Mouse Models

  2004cited by this paper
• In Vitro and In Vivo Characterization of Indium-111 and Technetium-99m Labeled CCK-8 Derivatives for CCK-B Receptor Imaging

  2004cited by this paper
• Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.

  2003cited by this paper
• Clinical applications of (18)F-FDG in oncology.

  2002cited by this paper
• A Novel DOTA-α-Melanocyte–Stimulating Hormone Analog for Metastatic Melanoma Diagnosis

  2002cited by this paper
• A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.

  2002cited by this paper
• In vivo evaluation of 188Re‐labeled alpha‐melanocyte stimulating hormone peptide analogs for melanoma therapy

  2002cited by this paper
• Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.

  2001cited by this paper
• Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

  2001cited by this paper
• Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.

  2000cited by this paper
• Therapeutic radiopharmaceuticals.

  1999cited by this paper
• Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.

  1998cited by this paper
• Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion.

  1996cited by this paper
• Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.

  1995cited by this paper
• Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic simulations

  1989cited by this paper
• Characterization of Receptors for α-Melanocyte-stimulating Hormone on Human Melanoma Cells

  1989cited by this paper
• Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.

  1989cited by this paper
• Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.

  1989cited by this paper
• Specific receptors for alpha-melanocyte-stimulating hormone are widely distributed in tissues of rodents.

  1987cited by this paper
• [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.

  1982cited by this paper

• Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH–Peptide Conjugates

  2024cites this paper
• Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands

  2024cites this paper
• Skin Cancer Pathobiology at a Glance: A Focus on Imaging Techniques and Their Potential for Improved Diagnosis and Surveillance in Clinical Cohorts

  2023cites this paper
• Development of Radiogallium-Labeled Peptides for Platelet-Derived Growth Factor Receptor β (PDGFRβ) Imaging: Influence of Different Linkers

  2020cites this paper
• The Influence of Different Spacers on Biological Profile of Peptide Radiopharmaceuticals for Diagnosis and Therapy of Human Cancers.

  2019cites this paper
• PET and SPECT imaging of melanoma: the state of the art

  2017influential citation
• Synthetic Peptide Drugs for Targeting Skin Cancer: Malignant Melanoma and Melanotic Lesions.

  2017cites this paper
• Evaluation of novel 111In-labeled gonadotropin-releasing hormone peptides for human prostate cancer imaging.

  2017cites this paper
• Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand

  2017cites this paper
• Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor

  2017influential citation
• Molecular imaging probes derived from natural peptides.

  2016cites this paper
• A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging

  2016cites this paper
• Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties.

  2016cites this paper
• Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging.

  2015cites this paper
• Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma

  2015cites this paper
• Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake

  2015cites this paper
• Development of a 99mTc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors

  2015cites this paper
• Introduction of an 8-Aminooctanoic Acid Linker Enhances Uptake of 99mTc-Labeled Lactam Bridge–Cyclized α-MSH Peptide in Melanoma

  2014cites this paper
• Substitution of the Lys Linker with the β-Ala Linker Dramatically Decreased the Renal Uptake of 99mTc-Labeled Arg-X-Asp-Conjugated and X-Ala-Asp-Conjugated α-Melanocyte Stimulating Hormone Peptides

  2014cites this paper
• Novel alpha-MSH peptide analogs for melanoma targeting

  2014cites this paper
• Novel 99mTc radiolabeled folate complexes with PEG linkers for FR-positive tumor imaging: synthesis and biological evaluation

  2014cites this paper
• Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides.

  2014cites this paper
• Effects of the Arg-Pro and Gly-Gly-Nle Moieties on Melanocortin-1 Receptor Binding Affinities of α-MSH Peptides.

  2013cites this paper
• Effects of amino acids on melanoma targeting and clearance properties of Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides.

  2013cites this paper
• Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

  2013cites this paper
• Malignant melanoma and melanocortin 1 receptor

  2013cites this paper
• Gene Therapy for Advanced Melanoma: Selective Targeting and Therapeutic Nucleic Acids

  2013cites this paper
• Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptide.

  2013cites this paper
• Evaluation of new Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides for melanoma imaging.

  2013cites this paper
• "Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.

  2013influential citation
• Evaluation of A Novel Arg-Gly-Asp-Conjugated Alpha-Melanocyte Stimulating Hormone Hybrid Peptide for Potential Melanoma Therapy

  2013influential citation
• Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging.

  2013cites this paper
• Peptide-receptor ligands and multivalent approach.

  2012cites this paper
• Optical and multimodal peptide-based probes for in vivo molecular imaging.

  2012cites this paper
• Copper-62 labeled ReCCMSH peptide analogs for melanoma PET imaging.

  2012cites this paper
• Facile synthesis and evaluation of C-functionalized benzyl-1-oxa-4,7,10-triazacyclododecane-N,N',N″-triacetic acid as chelating agent for ¹¹¹In-labeled polypeptides.

  2012cites this paper
• Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.

  2012cites this paper
• Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides.

  2012cites this paper
• Synthesis and biological evaluation of a novel (177)Lu-DOTA-[Gly(3)-cyclized(Dap(4), (d)-Phe(7), Asp(10))-Arg(11)]α-MSH(3-13) analogue for melanocortin-1 receptor-positive tumor targeting.

  2012cites this paper
• Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.

  2012cites this paper
• Substitution of Gly with Ala enhanced the melanoma uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.

  2012cites this paper
• Cu-64-labeled lactam bridge-cyclized α-MSH peptides for PET imaging of melanoma.

  2012cites this paper
• Iodine 125‐labeled mesenchymal–epithelial transition factor binding peptide‐click‐cRGDyk heterodimer for glioma imaging

  2011cites this paper
• Effects of the Amino Acid Linkers on the Melanoma-Targeting and Pharmacokinetic Properties of Indium-111-labeled Lactam Bridge-Cyclized α-MSH Peptides

  2011cites this paper
• Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.

  2011cites this paper
• Radiometallated peptides for molecular imaging and targeted therapy.

  2011cites this paper
• Effects of the Amino Acid Linkers on the Melanoma-Targeting and Pharmacokinetic Properties of 111In-Labeled Lactam Bridge–Cyclized α-MSH Peptides

  2011cites this paper
• Peptides and peptide hormones for molecular imaging and disease diagnosis.

  2010cites this paper
• Reduction of the Ring Size of Radiolabeled Lactam Bridge–Cyclized α-MSH Peptide, Resulting in Enhanced Melanoma Uptake

  2010cites this paper
• Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues.

  2010cites this paper
• A mild and efficient synthesis of monofluorinated α-lactam pseudopeptides via a novel dehydrofluorination of Ugi products

  2010cites this paper
• Melanocortin-1 receptor-targeting with radiolabeled cyclic α-melanocyte-stimulating hormone analogs for melanoma imaging.

  2010cites this paper
• Radiolabeled regulatory peptides for imaging and therapy

  2010cites this paper
• Inorganic nanoparticle-based contrast agents for molecular imaging.

  2010cites this paper
• MSH radiopeptides for targeting melanoma metastases.

  2010cites this paper
• Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.

  2009cites this paper
• Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.

  2009cites this paper
• Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.

  2009influential citation
• Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.

  2009cites this paper
• Molecular imaging targeting peptide receptors.

  2009cites this paper
• Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution.

  2009cites this paper
• Anatomical and molecular imaging of skin cancer

  2008cites this paper